Search Within

Hamza Hashmi

Formats
  1. Meeting Abstract (30)
  2. Journal Article (8)
  3. Research Letter (2)
  4. Review (2)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (20)
  2. Department of Medicine (20)
  3. Hematologic Malignancies, Division of (20)
  4. Bone Marrow Transplant (19)
  5. Myeloma (19)
  6. Survivorship Research (19)

More Groups

People
  1. Sridevi Rajeeve (21)
  2. Saad Usmani (20)
  3. Heather Landau (19)
  4. Sham Mailankody (19)
  5. Alexander Lesokhin (18)
  6. Carlyn Rose Tan (18)

More People

Years
  1. 2025 (3)
  2. 2024 (41)
Publications
  1. Blood (16)
  2. Clinical Lymphoma, Myeloma and Leukemia (15)
  3. Blood Cancer Journal (3)
  4. European Journal of Haematology (2)
  5. Blood Advances (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (17)
  2. Elsevier Inc. (16)
  3. John Wiley & Sons (3)
  4. Nature Publishing Group (3)
  5. Biomed Central Ltd (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of older adults and frail patients receiving idecabtagene vicleucel: A CIBMTR study
    Research Letter

    Akhtar, O. S.; Oloyede, T.; Brazauskas, R.; Afrough, A.; Hashmi, H.; Sidana, S.; Ahmed, N.; Bye, M.; Hansen, D.; Ferreri, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Research Letter

    Dileo, R.; Mewawalla, P.; Babu, K.; Yin, Y.; Strouse, C.; Chen, E.; Shaikh, H.; Davis, J. A.; Green, K. M.; Alkharabsheh, O.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • A real-world analysis of the safety and efficacy of BCMA-directed CAR T-cell therapy for patients with relapsed/refractory multiple myeloma and baseline renal impairment
    Meeting Abstract

    Habib, A.; Ahmed, N.; Khan, A. M.; Chang, D.; Paul, B.; Shaikh, H.; Strouse, C.; Struble, E.; Uegel, A.; Davis, J. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evaluation of teclistamab in BCMA-directed therapy exposed versus naive in relapsed/refractory multiple myeloma
    Meeting Abstract

    Snyder, J.; Graf, K.; Davis, J. A.; McKenna, M.; Tiger, Y. K.; Laharwal, M. M.; Mewawalla, P.; Alkharabsheh, O.; Hashmi, H.; Shaikh, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A real-world analysis of the safety and efficacy of teclistamab for patients with relapsed/refractory multiple myeloma and baseline renal impairment
    Meeting Abstract

    Habib, A.; Khan, A. M.; Laharwal, M. M.; Mewawalla, P.; McKenna, M.; Tiger, Y. K.; Shaikh, H.; Strouse, C.; Green, K. M.; Davis, J. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world efficacy outcomes of ciltacabtagene autoleucel in relapsed refractory multiple myeloma: A with the CARTITUDE-1 trial
    Meeting Abstract

    Kamboj, I.; Chang, D. R. Y.; Habib, A.; Vegel, A.; Struble, E.; Shaikh, H.; Strouse, C.; Davis, J. A.; Rashid, A.; Graf, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood (2024)

    Fulltext@MSK | Save